Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Membrane Transporter/Ion Channel-SGLT-Tofogliflozin hydrate
Tofogliflozin hydrate

Chemical Structure : Tofogliflozin hydrate

CAS No.: 1201913-82-7

Tofogliflozin hydrate (CSG452 hydrate, CSG-452 hydrate)

Catalog No.: PC-43518Not For Human Use, Lab Use Only.

Tofogliflozin (CSG-452) hydrate is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively.

Packing Price Stock Quantity
5 mg $98 In stock
10 mg $148 In stock
25 mg $268 In stock
50 mg $458 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Tofogliflozin (CSG-452) hydrate is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively.
Tofogliflozin (CSG-452) displays high selectivity over human SGLT2 versus human SGLT1, SGLT6, and sodium/myo-inositol transporter 1.
Tofogliflozin (CSG-452) increases renal glucose clearance and lowered the blood glucose level in Zucker diabetic fatty rats, also improves postprandial glucose excursion.
Tofogliflozin (CSG-452) reduces glycated hemoglobin and improved glucose tolerance in the oral glucose tolerance test in vivo.

Physicochemical Properties

M.Wt 404.45
Formula C22H28O7
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol, 6-[(4-ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-, hydrate (1:1), (1S,3'R,4'S,5'S,6'R)-

References

1. Suzuki M, et al. J Pharmacol Exp Ther. 2012 Jun;341(3):692-701.

2. Ohtake Y, et al. J Med Chem. 2012 Sep 13;55(17):7828-40.

3. Nagata T, et al. Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E414-23.

4. Nagata T, et al. Br J Pharmacol. 2013 Oct;170(3):519-31.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: